Biopharmaceutical company focused on innovative small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders
- Year invested 2011
- Investment Stage Public/PIPES
- Sectors
- Investment Status Historic
- Website acadia-pharm.com/
- Company Status Acquired (by Biovail Labratories) (NASDAQ: ACAD)